| Breast cancer: Biology, biomarkers, and treatments K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 84, 106535, 2020 | 473 | 2020 |
| Potential role of interferons in treating COVID-19 patients MH Abdolvahab, S Moradi-Kalbolandi, M Zarei, D Bose, K Majidzadeh-A, ... International immunopharmacology 90, 107171, 2021 | 77 | 2021 |
| Breast cancer immunotherapy: Current and novel approaches K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 98, 107886, 2021 | 62 | 2021 |
| Self-filling microwell arrays (SFMAs) for tumor spheroid formation A Seyfoori, E Samiei, N Jalili, B Godau, M Rahmanian, L Farahmand, ... Lab on a Chip 18 (22), 3516-3528, 2018 | 56 | 2018 |
| Triple-negative breast cancer: understanding Wnt signaling in drug resistance P Merikhian, MR Eisavand, L Farahmand Cancer cell international 21 (1), 419, 2021 | 48 | 2021 |
| Stimuli-responsive mesoporous silica NPs as non-viral dual siRNA/chemotherapy carriers for triple negative breast cancer B Darvishi, L Farahmand, K Majidzadeh-A Molecular Therapy-Nucleic Acids 7, 164-180, 2017 | 47 | 2017 |
| MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer P Merikhian, R Ghadirian, L Farahmand, S Mansouri, K Majidzadeh-A Expert Review of Anticancer Therapy 17 (7), 607-613, 2017 | 43 | 2017 |
| NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer B Darvishi, L Farahmand, Z Eslami-S, K Majidzadeh-A Tumor Biology 39 (6), 1010428317706919, 2017 | 43 | 2017 |
| The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific … B Darvishi, S Boroumandieh, K Majidzadeh-A, M Salehi, F Jafari, ... Experimental and molecular pathology 115, 104443, 2020 | 41 | 2020 |
| Significant role of MUC1 in development of resistance to currently existing anti-cancer therapeutic agents L Farahmand, P Merikhian, N Jalili, B Darvishi, K Majidzadeh-A Current Cancer Drug Targets 18 (8), 737-748, 2018 | 41 | 2018 |
| Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ... Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018 | 38 | 2018 |
| Interferons: Role in cancer therapy MH Abdolvahab, B Darvishi, M Zarei, K Majidzadeh-A, L Farahmand Immunotherapy 12 (11), 833-855, 2020 | 37 | 2020 |
| Challenges facing antiangiogenesis therapy: the significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor … A Mahdi, B Darvishi, K Majidzadeh‐A, M Salehi, L Farahmand Journal of Cellular Physiology 234 (5), 5655-5663, 2019 | 32 | 2019 |
| Naturally occurring compounds acting as potent anti‐metastatic agents and their suppressing effects on Hedgehog and WNT/β‐catenin signalling pathways L Farahmand, B Darvishi, K Majidzadeh‐A, A Madjid Ansari Cell Proliferation 50 (1), e12299, 2017 | 29 | 2017 |
| Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling F Khodabakhsh, P Merikhian, MR Eisavand, L Farahmand Cancer Cell International 21 (1), 200, 2021 | 28 | 2021 |
| The antiproliferative effects of cold atmospheric plasma‐activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism H Mokhtari, L Farahmand, K Yaserian, N Jalili, K Majidzadeh‐A Journal of Cellular Physiology 234 (5), 6778-6782, 2019 | 27 | 2019 |
| The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line L Farahmand, R Esmaeili, L Eini, K Majidzadeh-A Journal of cancer research and therapeutics 14 (2), 341-344, 2018 | 27 | 2018 |
| The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development S Moradi-Kalbolandi, K Majidzadeh-A, MH Abdolvahab, N Jalili, ... Probiotics and antimicrobial proteins, 1-15, 2021 | 26 | 2021 |
| Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides L Farahmand, B Darvishi, K Majidzadeh-A Drug Delivery 24 (1), 1249-1261, 2017 | 26 | 2017 |
| Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo M Barati, MA Javidi, B Darvishi, SP Shariatpanahi, ZSM Moosavi, ... Free Radical Biology and Medicine 169, 84-98, 2021 | 24 | 2021 |
